A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Jan, 2 2026
Oct, 7 2025
Jul, 7 2025
Feb, 11 2026
Dec, 31 2025